Vasoinhibitory effect of leminoprazole, a H+,K+-ATPase inhibitor, on rat aortic rings

General Pharmacology

Volumn 27, Issue 1, 1996, Pages 117-121

  Okabe, S ^a   Amagase, K ^a   Fujita, H ^a   Iwata, K ^a   Satake, N ^b   Shibata, S ^b  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

cGMP; cGMP PDE; Guanylate cyclase; Leminoprazole; Rat aortic rings; Verapamil; Voltage operated Ca2+ channels

Indexed keywords

ACETYLCHOLINE; CALCIUM; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CYCLIC GMP; CYCLIC GMP PHOSPHODIESTERASE; CYCLIC GMP PHOSPHODIESTERASE INHIBITOR; GLIBENCLAMIDE; GLYCERYL TRINITRATE; GUANYLATE CYCLASE INHIBITOR; IBERIOTOXIN; INDOMETACIN; LEMINOPRAZOLE; METHYLENE BLUE; N(G) METHYLARGININE; NIFEDIPINE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYLEPHRINE; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHLORIDE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTON PUMP INHIBITOR; UNCLASSIFIED DRUG; VERAPAMIL; ZAPRINAST;

ANIMAL TISSUE; AORTA; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; DRUG POTENTIATION; ISOLATED ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE RELAXATION; VASCULAR ENDOTHELIUM;

EID: 0029964101     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-3623(95)00083-6     Document Type: Article

References (11)

1. Bolotina V. M., Najibi S., Palacino J. J., Pagano P. J. and Cohen R. A. (1994) Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature, Lond. 368, 850-853.
2. Galvez A., Gimenez-Gallego G., Reuben J. P., Roy-Contancin L., Feigenbaum P., Kaczorowski G. and Garcia M. L. (1990) Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J. biol. Chem. 265, 11083-11090.
3. Gruetter C. A., Barry B. K., McNamara D. B., Gruetter D. Y., Kadowitz P. J. and Ignarro L. J. (1979) Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosamine. J. Cyclic nucl. Res. 5, 211-224.
4. Hibbs J. B. Jr., Taintor R. R. and Vaurin Z. (1987) Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 235, 473-476.
5. + channels in vasodilation induced by nitroglycerine, acetylcholine and nitric oxide. J. Pharmac. exp. Ther. 267, 1327-1335.
6. Okabe S., Akimoto Y., Yamasaki S. and Kuwahara K. (1991) Effects of a new benzimidazole derivative, NC-1300-O-3, on gastric secretion and gastroduodenal lesions in rats. Jpn. J. Pharmac. 55, 477-491.
7. Okabe S., Takagi K. and Inoue K. (1993a) Effect of NC-1300-O-3 on healing of acetic acid-induced gastric ulcers in rats. Jpn. J. Pharmac. 62, 25-33.
8. Okabe S., Takeuchi K., Ohuchi T., Yamamoto H. and Iwata K. (1993b) Effects of NC-1300-O-3 and omeprazole on gastric acid secretion, bicarbonate secretion gastric mucosal blood flow and transmucosal potential difference in rats. Ther. Res. 14, 3979-3996.
9. Okabe S., Amagase K., Fujita H., Iwata K., Shibata S. and Satake N. (1994a) Vasoinhibitory effects of NC-1300-O-3 and omeprazole in isolated rat aortas. Jpn. J. Pharmac. 64 (Suppl.), 166P.
10. Okabe S., Inoue K., Takagi K., Iwata K. and Yanagawa T. (1994b) Comparative studies of antisecretory, antiulcer and mucosal protective effects of NC-1300-O-3, cimetidine and omeprazole in rats. Ther. Res. 15, 349-366.
11. Palmer R. M. J., Rees D. D., Ashton D. S. and Moncada S. (1988) L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. biophys. Res. Commun. 153, 1251-1256.